Q2 2025 · 13F-HR
Deep Track Capital, LPholdings as filed
Filed 2025-08-14 · accession 0001856083-25-000004
$3.12B
Reported value
66
Positions
2025-06-30
Period end
The Brief · Deep Track Capital, LP · Q2 2025
AI · grounded in 13F
Deep Track Capital, LP established a new position in Guardant Health Inc GH valued at $221.2M. The fund also initiated new stakes in Ionis Pharmaceuticals Inc IONS for $193.3M and Protagonist Therapeutics Inc PTGX for $179.4M. Other new additions include Dynavax Technologies Corp DVAX and Insmid Inc INSM, both valued at approximately $176M. Total assets under management stand at $3.1B across 65 positions.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 40131M109 | GH | GUARDANT HEALTH INC | $221.2M | 7.09% | 4,250,000 | Common | SOLE |
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $193.3M | 6.20% | 4,891,544 | Common | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $179.4M | 5.75% | 3,245,899 | Common | SOLE |
| 268158201 | DVAX | DYNAVAX TECHNOLOGIES CORP | $176.5M | 5.66% | 17,791,486 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $176.1M | 5.65% | 1,750,000 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $162.4M | 5.21% | 3,042,598 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $152.0M | 4.87% | 9,500,000 | Common | SOLE |
| 67576A100 | OCUL | OCULAR THERAPEUTIX INC | $132.7M | 4.25% | 14,294,420 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $121.2M | 3.89% | 7,000,000 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $120.6M | 3.87% | 3,650,000 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $106.5M | 3.41% | 5,133,917 | Common | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $93.3M | 2.99% | 9,500,000 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $83.7M | 2.68% | 801,371 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $75.2M | 2.41% | 5,380,449 | Common | SOLE |
| 87650L103 | TARS | TARSUS PHARMACEUTICALS INC | $70.9M | 2.27% | 1,750,000 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $69.9M | 2.24% | 2,150,000 | Common | SOLE |
| 67080M103 | NRIX | NURIX THERAPEUTICS INC | $69.1M | 2.22% | 6,064,910 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $60.6M | 1.94% | 43,000,000 | Common | SOLE |
| 45258D105 | IMCR | IMMUNOCORE HLDGS PLC | $56.5M | 1.81% | 1,800,000 | Common | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $49.1M | 1.57% | 1,350,000 | Common | SOLE |
| 578784100 | MAZE | MAZE THERAPEUTICS INC | $48.5M | 1.55% | 3,948,910 | Common | SOLE |
| 00182C103 | ANIP | ANI PHARMACEUTICALS INC | $45.7M | 1.46% | 700,000 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $42.3M | 1.36% | 1,350,000 | Common | SOLE |
| 252828108 | DNTH | DIANTHUS THERAPEUTICS INC | $41.6M | 1.33% | 2,233,148 | Common | SOLE |
| 15117B202 | CLDX | CELLDEX THERAPEUTICS INC NEW | $40.7M | 1.31% | 2,000,000 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $38.9M | 1.25% | 900,000 | Common | SOLE |
| 05280R100 | AUTL | AUTOLUS THERAPEUTICS PLC | $38.4M | 1.23% | 16,852,147 | Common | SOLE |
| 59267L107 | — | METSERA INC | $31.1M | 1.00% | 1,094,408 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $28.0M | 0.90% | 7,495,000 | Common | SOLE |
| 878972108 | TECX | TECTONIC THERAPEUTIC INC | $27.9M | 0.89% | 1,401,938 | Common | SOLE |
| 00370M103 | ABVX | ABIVAX SA | $26.6M | 0.85% | 3,480,144 | Common | SOLE |
| 008064206 | JBIO | JADE BIOSCIENCES INC | $25.1M | 0.80% | 2,509,301 | Common | SOLE |
| 55287L101 | MBX | MBX BIOSCIENCES INC | $25.0M | 0.80% | 2,188,592 | Common | SOLE |
| 20451W101 | CMPS | COMPASS PATHWAYS PLC | $24.7M | 0.79% | 8,831,007 | Common | SOLE |
| G3855L106 | GHRS | GH RESEARCH PLC | $24.4M | 0.78% | 2,000,000 | Common | SOLE |
| 055477103 | BCAX | BICARA THERAPEUTICS INC | $22.5M | 0.72% | 2,426,657 | Common | SOLE |
| 687604108 | ORKA | ORUKA THERAPEUTICS INC | $21.5M | 0.69% | 1,918,798 | Common | SOLE |
| 29286M105 | — | ENGENE HOLDINGS INC | $16.6M | 0.53% | 4,557,575 | Common | SOLE |
| 60255C885 | BRD1EUR | MIND MEDICINE MINDMED INC | $16.2M | 0.52% | 2,500,000 | Common | SOLE |
| 91678A107 | UPB | UPSTREAM BIO INC | $15.8M | 0.51% | 1,442,767 | Common | SOLE |
| 68062P106 | OLMA | OLEMA PHARMACEUTICALS INC | $14.7M | 0.47% | 3,442,833 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $14.5M | 0.46% | 275,000 | Common | SOLE |
| 23256X407 | HELP | CYBIN INC | $12.8M | 0.41% | 1,529,987 | Common | SOLE |
| 171757206 | CDTX | CIDARA THERAPEUTICS INC | $12.2M | 0.39% | 250,000 | Common | SOLE |
| 088786108 | BCYC | BICYCLE THERAPEUTICS PLC | $8.4M | 0.27% | 1,203,244 | Common | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $7.7M | 0.25% | 450,000 | PUT | SOLE |
| G2545C104 | CBIO | CRESCENT BIOPHARMA INC. | $7.3M | 0.23% | 453,686 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS PLC | $6.6M | 0.21% | 500,000 | Common | SOLE |
| 670002401 | NVAX | NOVAVAX INC | $6.3M | 0.20% | 998,542 | Common | SOLE |
| 00534A102 | IVVD | INVIVYD INC | $6.1M | 0.20% | 8,585,980 | Common | SOLE |
| 75382E208 | RAPT | RAPT THERAPEUTICS INC | $6.0M | 0.19% | 751,422 | Common | SOLE |
| 21077P108 | CNTX | CONTEXT THERAPEUTICS INC | $4.9M | 0.16% | 7,419,355 | Common | SOLE |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $4.6M | 0.15% | 3,947,807 | Common | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $4.4M | 0.14% | 259,800 | Common | SOLE |
| 98401F105 | XNCR | XENCOR INC | $4.3M | 0.14% | 549,439 | Common | SOLE |
| 45773H409 | INO | INOVIO PHARMACEUTICALS INC | $4.0M | 0.13% | 1,981,370 | Common | SOLE |
| 500946108 | KRRO | KORRO BIO INC | $3.5M | 0.11% | 277,966 | Common | SOLE |
| 45175G108 | — | IKENA ONCOLOGY INC | $3.4M | 0.11% | 2,515,513 | Common | SOLE |
| 00773J202 | SYRE | SPYRE THERAPEUTICS INC | $3.3M | 0.11% | 219,015 | Common | SOLE |
| 01626L204 | ALGS | ALIGOS THERAPEUTICS INC | $3.2M | 0.10% | 444,110 | Common | SOLE |
| 05338F306 | AVTX | AVALO THERAPEUTICS INC | $2.8M | 0.09% | 567,103 | Common | SOLE |
| G9TY5A101 | ZURA | ZURA BIO LTD | $1.8M | 0.06% | 1,727,562 | Common | SOLE |
| 28658R106 | CLYM | CLIMB BIO INC | $1.3M | 0.04% | 1,040,115 | Common | SOLE |
| 81734D104 | SEPN | SEPTERNA INC | $1.3M | 0.04% | 121,716 | Common | SOLE |
| 75383L102 | RAPP | RAPPORT THERAPEUTICS INC | $1.1M | 0.04% | 98,237 | Common | SOLE |
| 68277Q105 | OKUR | ONKURE THERAPEUTICS INC | $431,419 | 0.01% | 180,510 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.